ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,275,000 | -2.9% | 65,516 | -29.2% | 0.06% | -12.7% |
| Q2 2021 | $11,606,000 | +498.2% | 92,487 | +546.4% | 0.07% | +446.2% |
| Q1 2021 | $1,940,000 | +50.2% | 14,307 | +41.7% | 0.01% | +44.4% |
| Q4 2020 | $1,292,000 | +112.5% | 10,100 | +87.0% | 0.01% | +125.0% |
| Q3 2020 | $608,000 | -42.5% | 5,400 | -51.4% | 0.00% | -55.6% |
| Q2 2020 | $1,057,000 | – | 11,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |